The rise of Sildenafil initially sparked a period of growth for the drug industry, however recent shifts present a murky picture for investors. Lower-cost competitors are eating into revenue, and continued litigation https://saulffuh270278.ambien-blog.com/48046652/the-blue-pill-and-pharma-a-volatile-investment